TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds April 24, 2009
TCL Archive In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal July 15, 1994
TCL Archive GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants August 13, 1976
